No Carolina / NY / Florida
Ph: 561.316.3330

HomeEXECUTIVES

Category: EXECUTIVES

Avation Medical Adds Vice President...

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Xeno Biosciences Welcomes New CEO,...

Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.

Avation Medical Adds Vice President of Market Access

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”

Nordson Corporation Names Joseph P Kelley as Chief Financial Officer

Joseph P Kelley brings over 25 years of financial and operational expertise to the role. Since 2015, he has served as CFO of Materion, a $1.2 billion advanced materials company.

Drew Mellan New Director of Account Management of Noble

In this new position, Drew Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.

Dr Peter Meintjes joins Transplant Genomics as CCO

Dr Peter Meintjes joins TGI after six years at Omixon, a world leader in pre-transplant HLA Typing, where he departs as CEO, having grown the company at a CAGR of >75% since its first full year of operation as a molecular diagnostics company.

Orchestra BioMed Enhances Management Team with Appointment of Regulatory Affairs and Combination Product Expert Bob Laughner as Vice President, Regulatory Affairs

Bob Laughner will play a lead role in advancing Orchestra BioMed’s Virtue® Sirolimus AngioInfusion™ Balloon (SAB) through global regulatory approvals.

Dr Efthymios Deliargyris Appointed New CMO of Cytosorbents

Dr Efthymios Deliargyris brings over 19 years of experience in both academic medicine and industry to the position of Chief Medical Officer. 

John Murphy PhD Appointed GTX Medical BV Chief Technology Officer

John Murphy PhD joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization.

Dan Myers Appointed CEO of Leo Lens Pharma

Prior to joining Leo Lens Pharma, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors.

CHPA Welcomes Procter & Gamble’s Paul Gama as Board Chair

Gama is President of Personal Health Care (PHC) for The Procter & Gamble Company (P&G), leading their global healthcare portfolio of OTC medicines, dietary supplements, and consumer medical devices.

Nathan Diers Promoted Vice President of EyeKor Product Development

Yijun Huang, CEO of EyeKor, is thrilled with this new promotion. Huang said, "Nathan Diers has been an integral part of EyeKor's growth.

By using this website you agree to accept Medical Device News Magazine Privacy Policy